市場調査レポート

バイオバンキング:アプリケーション - 世界市場動向(2009〜2015年)

Biobanking: Applications - A Global Market Watch, 2009-2015

発行 Axis Research Mind 商品コード 222812
出版日 ページ情報 英文 656 Pages; 176 Tables/Charts
納期: 即日から翌営業日
価格
こちらの商品の販売は終了いたしました。
Back to Top
バイオバンキング:アプリケーション - 世界市場動向(2009〜2015年) Biobanking: Applications - A Global Market Watch, 2009-2015
出版日: 2011年11月07日 ページ情報: 英文 656 Pages; 176 Tables/Charts

当商品の販売は、2016年05月06日を持ちまして終了しました。

概要

世界のバイオレポジトリ市場は2015年までに239億米ドル規模になると予測されています。北米が市場全体の30%以上を占めており、国ベースでは米国が最大のシェアを有しています。またインドや中国は成長率では米国を凌ぎ、近い将来市場をリードするとみられています。

当レポートは、バイオバンキング市場の最新動向、地域別需要、幹細胞、血液製剤、動物医療などの応用分野別動向と2009〜2015年の予測をまとめ、概略以下の構成でお届けします。

第1章 本書の焦点

  • イントロダクション
    • バイオレポジトリ
    • バイオ標本
    • 長期的保存のためのバイオレポジトリと将来分析
    • プライバシー法がレポジトリとデータベースに及ぼす影響
    • 将来のバイオレポジトリ見通し
  • バイオバンクのレビュー
    • バイオバンクの種類
    • 近代的バイオバンクのニーズ
    • バイオバンキングのコスト
    • バイオバンクに関わる様々な因子
    • バイオレポジトリサービス
    • バイオバンキングのメリット
    • 医療環境におけるバイオバンキングの役割
    • 標的癌治療のためのバイオ標本の役割
  • バイオバンキングにおけるバイオマーカーのレビュー
  • 世界のバイオバンキングのレビュー
    • 北米
    • 欧州
    • アジア太平洋地域
  • 国際的法規制イニシアティブ

第2章 市場分析

  • バイオレポジトリ/バイオバンキング:応用セグメンテーション
    • 国別分析
    • 応用
    • 幹細胞
    • 血液製剤
    • ヒト
    • 動物医療
    • 最新用途
    • ゲノミクス
    • 法医学
    • その他の応用
  • 成長率分析
    • バイオレポジトリ市場:応用
    • 最新応用市場
  • 投資対象

第3章 業界概要

  • バイオレポジトリと世界的ネットワーキング
  • ヒト遺伝子バイオバンク:政策と科学的進歩
  • バイオバンキングのキーポイント
  • バイオバンク、バイオ標本研究のための一般的基準
  • 幹細胞バイオバンキング
  • 小児科におけるバイオバンキング
  • 業界活動
    • 合併・買収・提携・特許・合弁
  • 市場動向
  • 業界リーダー
  • バイオレポジトリとバイオバンキングの将来
  • 企業プロファイル

第4章 業界企業データベース

第5章 付録

目次
Product Code: ARMMR163

Abstract

SEGMENTATION

BIOBANKING APPLICATIONS

  • Stem Cells
  • Blood Products
  • Human (Tissue Sections, Brain, Liver, Eyes, Heart, Kidney and Others)
  • Veterinary
  • Advanced Applications &
    • Genomics (DNA, RNA, Protein Extraction, Molecular Derivatives, Cell Cultures, Microarrays, Cytogenetics, etc.)
    • Drug Discovery &
    • Forensics
  • Other

"Learn High Potential Market Dynamics for Strategic Business Planning"

The 'Biobanking: Applications - A Global Market Watch, 2009-2015' reviews the latest trends in biobanking sector with a perceptive to disclose the near-future growth prospects in. An in-depth analysis across the geographic regions provides strategic business intelligence for life science and as well as healthcare sector investments. The study offers profitable investment strategies for R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations.

The report focuses on the current market trends, estimates and forecasts for the period 2009-2015. More than 1100 in biorepositories market and 120 leading market players that project improved market activities in the near future are profiled. The report consists of 176 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market. Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases and published research reports are also used for estimates. Estimates have incorporated recessionary impact on the industry. The analysis is based on desk research and interviews with biobank researchers and law/ethics specialists, as well as on data collected through the survey, and discussions with experts.

KEY COMPANIES PROFILED

Thermo Fisher Scientific, Sanyo Biomedical, New Brunswick Scientific, Labvantage Solutions, Inc., Labware, Inc., Starlims Corporation, Genvault Corporation, Qiagen, Tecan, Beckman Coulter, ATGC Labs, Dataworks Development, Inc., Biostorage Technologies, Inc., Pacific Bio-Material Management, Inc., Promeddx, Llc, Seqwright DNA Technology Services, Steelgate, Inc., Wheaton, Vivakor, Inc, Novare Biologistics, Autogen, Inc., & many more....

BIOREPOSITORIES / BIOBANKING

"Getting the Most from Our Research Analysis"

With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of the market. While US accounts for the highest share of the global market value on a country basis, India and China surpasses the US in terms of growth rate anticipated in the near future and leads the world. Share of stem cells market in Biorepositories is forecasted to become nearly 30% by 2015, with a massive CAGR of 18.7%. Among the segments, blood Products market is expected to reach US$2.8 billion. Our analysis indicates that human and veterinary uses would worth US$2.6 billion and US$2.8 billion, respectively by 2015.

GEOGRAPHIC COVERAGE

Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan and China along with the other emerging countries are estimated individually for the upcoming years. Anticipating a protracted economic recovery towards to 2011 and based on the CAGR estimates and growth potential, we have forecasted the market size figures for the next five years.

The region-wise distribution of the market consists of North America, Europe, Asia-Pacific and Rest of World with 22 countries, analyzed individually as follows:

NORTH AMERICA

  • USA, CANADA & MEXICO

EUROPE

  • BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM & REST OF EUROPE1

ASIA-PACIFIC

  • AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA & REST OF ASIA-PACIFIC2

REST OF THE WORLD

  • ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA & REST OF REST OF WORLD
  • 1. Rest of Europe Includes Austria, Poland, Russia, Switzerland, Finland, The Netherlands, Hungary and Others.
  • 2. Rest of Asia-Pacific Includes Hong Kong, New Zealand, Singapore, Taiwan, Thailand and Others.

KEY INDUSTRY ACTIVITIES

  • NEW-FANGLED CLEAN ROOM MONITORING SOLUTION BY VERITEQ
  • THERMO FISHER SCIENTIFIC ACQUIRES 'EASY-NLC' PROVIDER PROXEON
  • HUNT BIOSCIENCES SIGNS COLLABORATION AGREEMENT WITH TISSUE SOLUTIONS
  • STEM CELL THERAPY A MAJOR ROLE FOR ACUTE LUNG DAMAGE IN MICE
  • VAISALA ACQUIRES VERITEQ INSTRUMENTS
  • THERMO FISHER SCIENTIFIC AND LILLY MAKE FIVE-YEAR AGREEMENT FOR CLINICAL TRIAL MATERIALS RELATIONSHIP
  • ACCESS TO TISSUES FOR ONCOLOGY R & D
  • STRATEGIC ALLIANCE FOR SAMPLE STORAGE AND CONVERSION SERVICES
  • BIOCISION COLLABORATED WITH SERVA ELECTROPHORESIS
  • UNSWERVING WASHING NEXTERIONR PLATES BY TECANHYDROFLEX™
  • CARDIOVASCULAR GENETIC TESTING AT BERKELEY HEARTLAB MADE EASY WITH GENTEGRA™ DNA FROM GENVAULT
  • CALIPER ANNULS LAWSUIT AGAINST SHIMADZU
  • TRANS-HIT LAUNCHES "QUICK OPPORTUNITIES"
  • THERMO FISHER SCIENTIFIC TAKES OVER FINNZYMES WHOLLY
  • THERMO FISHER SCIENTIFIC ACQUIRES AHURA SCIENTIFIC
  • STARLIMS SHAREHOLDERS APPROVE OF ACQUISITION BY ABBOTT
  • VERITEQ' S 10-STEP GUIDE ON "HOW TO RESPOND TO (AND AVOID) FDA 483S"
  • BIOCISION LANDS NEW DISTRIBUTION PARTNER WITH BIOPHORETICS DEAL
  • AUTOMATION BOOSTS SAMPLE PREPARATION FOR NEXT-GENERATION SEQUENCING
  • U.S. NATIONAL CANCER INSTITUTE CHOOSES INDIVUMED TO STUDY THE INTEGRITY OF BIOSPECIMEN SAMPLING PROCEDURES
  • CALIPER LAUNCHES SCICLONE G3
  • THERMO FISHER SCIENTIFIC SIGNS FINAL AGREEMENT TO ACQUIRE AHURA SCIENTIFIC
  • ANNOUNCING THE LAUNCH OF SANYO PROFESSIONAL AIR WASHER PLUSTM FOR COMMERCIAL ENVIRONMENTS, SUPPRESSING VOCS, BACTERIA, AIRBORNE GERMS, MOLD, ODOR AND ALLERGENS
  • CALIPER AGREES TO LICENSE MICROFLUIDICS IP TO BECTON DICKINSON
  • GENTEGRA™ RNA INTRODUCED BY GENVAULT CORPORATION
  • OCIMUM BIOSOLUTIONS STANDS IN 4TH PLACE AS THE FASTEST GROWING TECHNOLOGY COMPANY

& many more....

Table of Contents

I. REPORT FOCUS

A. INTRODUCTION

1. BIOREPOSITORIES

  • BIOREPOSITORY OPERATIONS
  • BIOSPECIMEN SECURITY AND STORAGE

WORLDWIDE BIOREPOSITORIES

  • VOUCHER SPECIMENS LINKED BY SEQUENCE DATA RECORDS
  • INSTITUTIONAL/NON-INSTITUTIONAL ACRONYMS AND COLLECTION CODES
  • CONSERVATION OF BIOREPOSITORIES AND ASSOCIATED DATABASES
  • BIOREPOSITORIES FROM RECENT CANCER PREVENTION TRIALS
  • DNA BIOBANKS WITH AUTOMATED DNA EXTRACTION AND NORMALIZATION
  • DNA ELUTION AND NORMALIZATION

2. BIOSPECIMENS

  • BIOSPECIMENS IN CANCER RESEARCH
  • BIOSPECIMENS - THE LEGACY PLAN
  • DECADES OLD SPECIMENS MAY BE TODAY'S RESEARCH TREASURES

3. BIOREPOSITORIES FOR LONG-TERM PRESERVATION AND FUTURE ANALYSIS

  • BIOSPECIMEN SAMPLE COLLECTION AND PREPARATION
  • CONSIDERATIONS FOR LONG-TERM SAMPLE STORAGE
  • POLICES FOR SAMPLE STORAGE
  • INFORMATION MANAGEMENT AND AUDIT TRAILS
  • BIOREPOSITORY CAPABILITIES
  • COLD CHAIN LOGISTICS
  • CONCLUSION

4. OVERVIEW OF THE PRIVACY RULE'S IMPACT ON REPOSITORIES AND DATABASES

  • ALTERATION OF THE AUTHORIZATION REQUIREMENT BY AN IRB OR PRIVACY BOARD
  • OTHER PRIVACY RULE REQUIREMENTS
  • MINIMUM NECESSARY STANDARD
  • RIGHT TO AN ACCOUNTING OF DISCLOSURES

5. MAJOR PROSPECTS FOR BIOREPOSITORIES IN THE FUTURE

  • THE KEY IMPACT OF BIOREPOSITORIES IN ITS APPLICATIONS

BIGGEST CHALLENGES AND OPPORTUNITIES IN BIOREPOSITORIES

  • BIGGEST CHALLENGES
  • BIGGEST OPPORTUNITIES
  • PRESENT CHALLENGES OF BIOBANKING: BIOETHICAL AND PROPERTY ISSUES

ADDED VALUE OF BIOBANKS FOR HEALTH: AN EVOLUTIONARY PERSPECTIVE

  • FUTURE CHALLENGES
  • CONCLUSIONS

B. A REVIEW ON BIO "BANKS"

  • RELEVANCE OF BIOBANKS IN SCIENTIFIC RESEARCH

BIOBANKS TYPES

  • POPULATION-BASED BIOBANKS
  • PUBLIC BIOBANKING
  • AROUND THE WORLD AND WITHIN THE USA
  • THE PUBLIC POPULATION PROJECT IN GENOMICS (P3G)

THE NEED OF MODERN BIOBANKS

  • BENEFITS

BIOBANKING COSTS

  • PROCEDURE OF ESTIMATING THE BIOBANKING COST
  • FACTORS INFLUENCING BIOBANKS PRICES
  • COST STRUCTURE
  • INSTITUTIONAL
  • GOVERNMENT
  • ACCESS
  • MARKET FORCES

DIFFERENT TYPES OF ACTORS INVOLVED IN BIOBANKS

BIOREPOSITORY SERVICES

1. BIOBANKING BENEFITS

  • CONCLUSION

2. CURRENT ROLE OF BIOBANKING IN MEDICAL ENVIRONMENT

  • A CASE FOR OUTSOURCING
  • A BIOMATERIAL STORAGE PROVIDER
  • COLD-CHAIN MANAGEMENT, TRACKING AND MONITORING
  • BIOREPOSITORY COSTS
  • SAMPLE INTEGRITY
  • THE FUTURE OF BIOREPOSITORIES
  • THE VALUE OF BIOLOGICAL SPECIMENS AND MEDICAL INFORMATION FOR MEDICAL RESEARCH

3. THE ROLE OF BIOSPECIMENS FOR DISCOVERY OF A TARGETED CANCER THERAPY

4. A REVIEW ON BIOMARKERS IN BIOBANKING

  • ROLE OF BIO-BANKS IN BIOMARKER-RELATED RESEARCH
  • CONSENSUS GUIDELINES FOR CSF BIOBANKING AND BLOOD BIOBANKING FOR CNS BIOMARKER STUDIES
  • COLLECTION PROCESS
  • STORAGE PROCESS
  • SAMPLES ADMINISTRATION PROCESS
  • MAINTENANCE OF PATIENT INFORMATION DATABASE
  • CONCLUSION

BRAIN/TISSUE/BIOBANKS (BTB) BANKS FOR BIOMARKERS IN NEUROLOGICAL DISORDERS

BIOMARKERS IN CLINICAL USE - THERAPEUTIC AREA - GLOBAL

5. A REVIEW ON GLOBAL BIOBANKING

  • RESEARCH BIOBANKING IN THE GLOBAL CONTEXT: PROS AND CONS

5.1. NORTH AMERICA

  • BIOBANKING IN THE USA
  • STEM CELL BANKS
  • LIST OF STUDIES USING BLOOD SPECIMENS / DNA RESEARCH BANKS IN THE US
  • TISSUE BANK/BLOOD BANK RESOURCES
  • REGULATORY ASPECTS
  • ETHICS DISCUSSION

BIOBANKING IN CANADA

  • REGULATORY ASPECTS
  • ETHICS DISCUSSION
  • BLOOD SPECIMENS AND DNA RESEARCH BANKS
  • TISSUE COLLECTION BANKS

BIOBANKING IN LUXEMBOURG

  • GUIDELINES

BIOREPOSITORIES / BIOBANKING - NORTH AMERICAN MARKET BRIEFING

  • APPLICATIONS
  • BIOREPOSITORIES - APPLICATIONS - ADVANCE APPLICATIONS

5.2. EUROPE

  • INTRODUCTION

IMPACT OF POPULATION SURVEYS AND BIOBANKING

  • HEALTH POTENTIAL
  • SOCIO-ECONOMIC POTENTIAL
  • INDUSTRY POTENTIAL
  • LEGAL, POLITICAL AND SOCIAL POTENTIAL

EUROPEAN STRENGTHS

  • INTERNATIONAL CONTEXT
  • KEY CHALLENGES OF EUROPEAN BIOBANKING
  • FUNDING

RECOMMENDATIONS FOR EUROPEAN BIOBANKING AND POPULATION SURVEYING

  • GOAL
  • SCOPE
  • LEGAL AND ETHICAL FRAMEWORK FOR COLLABORATIVE BIOBANKING ACROSS EUROPE

EXTENT OF BIOBANKING IN EUROPE

  • CHALLENGES IN IMPROVING BIOBANKING
  • TECHNOLOGICAL CHALLENGES
  • DATA COMPARABILITY AND STANDARDIZATION (IT & BIOINFORMATICS)
  • LEGAL, REGULATORY AND ETHICAL REQUIREMENTS
  • PRIVACY PROTECTION AND SECURITY ISSUES
  • ROLE OF ETHICS REVIEW BOARDS
  • NETWORKING AMONG "SMALLER" BIOBANKS
  • CONCLUSION

REGULATORY ASPECTS

  • EUROPEAN BIOBANKING INDUSTRY COMPARISON: PRESENT AND THE NEXT 10 YEARS

BIOBANKING IN SWEDEN

  • REGULATORY ASPECTS
  • ETHICS DISCUSSION
  • BIOBANKS IN SWEDEN

BIOBANKING IN NORWAY

  • REGULATORY ASPECTS
  • BIOBANKS IN NORWAY

BIOBANKING IN DENMARK

  • REGULATORY ASPECTS
  • BIOBANKS IN DENMARK

BIOBANKING IN FINLAND

  • REGULATORY ASPECTS
  • BIOBANKS IN FINLAND

BIOBANKING IN ICELAND

  • REGULATORY ASPECTS
  • ETHICS DISCUSSION
  • BIOBANKS IN ICELAND

BIOBANKING IN SPAIN

  • STRENGTHS
  • WEAKNESSES
  • THE SPANISH SCIENTIFIC ENVIRONMENT
  • REGULATORY ASPECTS

BIOBANKING IN THE UNITED KINGDOM

  • CORD BLOOD BANKING
  • REGULATORY ASPECTS
  • ETHICS DISCUSSION
  • BIOBANKS IN THE UNITED KINGDOM

BIOBANKING IN HUNGARY

  • BIOBANKING COMPANIES IN HUNGARY

BIOBANKS IN ROMANIA

  • REGULATORY ASPECTS

BIOBANKING IN AUSTRIA

  • REGULATORY ASPECTS
  • ETHICS DISCUSSION

BIOBANKING IN BELGIUM

  • REGULATORY ASPECTS

BIOBANKING IN GERMANY

  • REGULATORY ASPECTS
  • ETHICS DISCUSSION

BIOBANKING IN THE NETHERLANDS

  • PUBLIC BIOBANKS FOR RESEARCH PURPOSES IN THE NETHERLANDS
  • COMMERCIAL BIOBANKS
  • REGULATORY ASPECTS

BIOBANKING IN ITALY

  • REGULATORY ASPECTS
  • BIOBANKS IN ITALY

BIOBANKING IN FRANCE

  • REGULATORY ASPECTS

BIOBANKING IN REST OF EUROPE

  • BALTIC COUNTRIES
  • REGULATORY ASPECTS
  • ETHICS DISCUSSION
  • BIOBANKS IN BALTIC COUNTRIES
  • BIOBANKS IN SOUTHERN EUROPE

BIOBANKING IN IRELAND

  • GUIDELINES

BIOREPOSITORIES / BIOBANKING - EUROPEAN MARKET BRIEFING

  • APPLICATIONS
  • BIOREPOSITORIES - APPLICATIONS - ADVANCE APPLICATIONS

5.3. ASIA-PACIFIC

  • BIOBANKING IN JAPAN
  • BIOBANKS IN JAPAN

BIOBANKING IN SINGAPORE

  • ACTIVITIES
  • RESEARCH & DEVELOPMENT
  • RESOURCES & INFRASTRUCTURE
  • TRAINING AND EDUCATION
  • BIOBANKS IN SINGAPORE

BIOBANKING IN CHINA

BIOBANKING IN INDIA

  • ETHICAL DISCUSSION
  • BIOBANKS IN INDIA
  • BIOBANKING GUIDELINES

BIOBANKING IN SOUTH KOREA

  • BIOBANKS IN SOUTH KOREA

BIOBANKING IN TAIWAN

BIOBANKING IN THE REST OF ASIA-PACIFIC

  • REGULATORY ASPECTS
  • ETHICAL DISCUSSION
  • BIOBANKS IN THE REST OF ASIA-PACIFIC

BIOREPOSITORIES / BIOBANKING - ASIA-PACIFIC MARKET BRIEFING

  • APPLICATIONS
  • BIOREPOSITORIES - APPLICATIONS - ADVANCE APPLICATIONS

6. INTERNATIONAL REGULATORY INITIATIVES

II. MARKET ANALYSIS

BIOREPOSITORIES / BIOBANKING: APPLICATIONS - INDUSTRY SNAPSHOT

A. BIOREPOSITORIES / BIOBANKING: APPLICATIONS - SEGMENTATION

  • BIOREPOSITORIES - GLOBAL

BIOREPOSITORIES - BY - COUNTRY ANALYSIS

  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

BIOREPOSITORIES - APPLICATIONS - GLOBAL

  • BIOREPOSITORIES - APPLICATIONS - GEOGRAPHIC REGION
  • STEM CELLS
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

BLOOD PRODUCTS

  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

HUMAN

  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

VETERINARY

  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

ADVANCED APPLICATIONS

  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

BIOREPOSITORIES - ADVANCE APPLICATIONS - BY TYPE

  • BIOREPOSITORIES - ADVANCE APPLICATIONSBY TYPE - GEOGRAPHIC REGION
  • DRUG DISCOVERY
  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

GENOMICS

  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

FORENSICS

  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

OTHER APPLICATIONS

  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

B. GROWTH RATE ANALYSIS

  • GLOBAL BIOREPOSITORIES MARKET GROWTH RATES
  • BIOREPOSITORIES MARKET - APPLICATIONS
  • GLOBAL BIOREPOSITORIES APPLICATIONS TYPES - GROWTH RATES
  • GLOBAL STEM CELLS MARKET GROWTH RATES
  • GLOBAL BLOOD PRODUCTS MARKET GROWTH RATES
  • GLOBAL HUMAN BIOBANKING MARKET GROWTH RATES
  • GLOBAL VETERINARY MARKET GROWTH RATES
  • GLOBAL ADVANCED APPLICATIONS MARKET GROWTH RATES

BIOREPOSITORIES ADVANCED APPLICATIONS MARKET - TYPES

  • GLOBAL BIOREPOSITORIES ADVANCED APPLICATIONS TYPES - GROWTH RATES
  • GLOBAL DRUG DISCOVERY MARKET GROWTH RATES
  • GLOBAL GENOMICS MARKET GROWTH RATES
  • GLOBAL FORENSICS MARKET GROWTH RATES

C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW

A. BIOREPOSITORIES AND GLOBAL NETWORKING

  • BIOBANKING TRENDS, CHALLENGES AND OPPORTUNITIES
  • BIOBANKS: TRANSNATIONAL, EUROPEAN AND GLOBAL NETWORKS
  • WIPING OUT CHRONIC DISEASE MAY ADD 10% TO SOUTH ASIA GDP

B. HUMAN GENETIC BIOBANKS: POLITICS OF TRUST AND SCIENTIFIC ADVANCEMENT

C. KEY POINTS IN BIOBANKING INCLUDES: DEVELOPMENT, COLLECTION, INFORMATICS, REGULATORY, LEGAL AND ETHICAL ISSUES

D. WORKSHOP ON COMMON STANDARDS FOR BIOBANKS AND BIOSPECIMEN RESEARCH

E. STEM CELLS BIOBANKING - A RAPID GROWING MARKET

STEM CELLS - MARKET TRENDS

  • STEM CELL TREATMENTS GIVE NEW EXPECTATION
  • DONOR STEM CELL RESEARCH MAY REPAIR HEART DAMAGE
  • ANTI-AGING INDUSTRY GOES FOR STEM CELL THERAPY
  • STEM CELL TREATMENT TO CURE DIABETES
  • HOTTEST DEVELOPMENTS IN STEM CELLS TREATMENTS
  • STEM CELL PROGRESS BEING HIT BY TRADITIONALIST

WORLD MARROW DONOR ASSOCIATION (WMDA)

ASIA AT WMDA

F. BIOBANKING IN PEDIATRICS: THE HUMAN NON-SUBJECTS APPROACH

  • INTRODUCTION
  • FUTURE PERSPECTIVE

G. INDUSTRY ACTIVITIES

  • MERGERS/ACQUISITIONS/AGREEMENTS/PATENTS GRANTS/JOINT VENTURES/ETC......
  • ARGENTA AND BIOFOCUS EXTEND DRUG DISCOVERY COLLABORATION WITH GENENTECH
  • THERMO FISHER SCIENTIFIC LAUNCHES HYPERSEP™ SLE SAMPLE PREPARATION OPTION
  • SEWARD STOMACHERR 400 CIRCULATOR FOR E.COLI 0157 FOOD SAFETY STUDY
  • PORVAIR SCIENCES - SPECIALISTS IN CUSTOM MANUFACTURE OF MICROPLATES
  • THERMO FISHER SCIENTIFIC LAUNCHES HISTOSTAR EMBEDDING SYSTEM
  • COTI-2 - A MILESTONE FOR CRITICAL OUTCOME TECHNOLOGIES
  • STRATOPHASE'S OPTICAL BIODETECTOR TO DETECT RICIN AND ANTHRAX TOXIN IN TESTS
  • IMPACT OF PRODUCT RESISTANCE ON PRIMARY FREEZE DRYING
  • INTEGRA ENLIGHTENS USE OF VIAFLO 96* AND VIAFLO VOYAGER**
  • GENEVAC LAUNCHES HT SERIES II SOLVENT EVAPORATORS
  • ENCAP DRUG DELIVERY LAUNCHES COLON-SCREEN
  • BOEHRINGER INGELHEIM SIGNS LICENSING AGREEMENT FOR PROBIOGEN'S GLYMAXXR TECHNOLOGY
  • APCETH OBTAINS MANUFACTURER'S LICENSE FOR SOMATIC CELL THERAPY
  • CHART INDUSTRIES ACQUIRES THE GOFA GROUP
  • INC RESEARCH AND DEBIOPHARM GROUP ™ ENTER INTO STRATEGIC PARTNERSHIP
  • ORASURE TECHNOLOGIES WILL ACQUIRE DNA GENOTEK
  • BROOKS AUTOMATION ACQUIRES NEXUS BIOSYSTEMS
  • BROOKS AUTOMATION SUPPLIES SMARRTSTORE DNA STORAGE SYSTEM TO LIFELINES
  • CEPHALON'S FENTORA AND ACTIQ OBTAIN FDA APPROVAL FOR RISK EVALUATION AND MITIGATION STRATEGY
  • NEW TOOLS FOR CELL CRYOPRESERVATION BY BIOCISION
  • LABVANTAGE SELECTED FOR PROVIDING WORLD-CLASS SERVICES, BY LEADING FOOD SAFETY AND QUALITY ORGANIZATION
  • TECAN AND TECHNICAL COMMUNITIES VENTURED WITH THE GOVERNMENT
  • GERMANY SELECTS QIAGEN AS COMPANY WITH MOST INNOVATIVE MANAGEMENT STRATEGY
  • DNA GENOTEK'S ORAGENER" DNA COLLECTION KIT SELECTED BY EXISTENCE GENETICS FOR PREDICTIVE MEDICINE SERVICE
  • BECKMAN COULTER DEMONSTRATES LS 13 320 LASER DIFFRACTION ANALYZER AND CELEBRATES FOOD AT IFT CONFERENCE
  • BECKMAN COULTER'S CESI 8000 HIGH-PERFORMANCE SEPARATION-ESI MODULE WITH OPTIMS TECHNOLOGY - A BLESSING FOR MASS SPECTROMETRY
  • SAIC-FREDERICK AND BIOMATRICA COLLABORATE TO IMPROVE MOLECULAR ANALYSIS IN CANCER RESEARCH
  • ASTERAND AND 5AM SOLUTIONS SIGN A PREFERRED PARTNERSHIP AGREEMENT
  • BIOSTORAGE TECHNOLOGIES INAUGURATES NEW BIOREPOSITORY IN INDIANAPOLIS
  • BIOSTORAGE TECHNOLOGIES OPENS A NEW BIOREPOSITORY FACILITY
  • INTERNATIONAL COLLABORATION ON ADHD AND SUBSTANCE ABUSE (ICASA) CHOOSES DNA GENOTEK'S ORAGENE" DNA
  • SANYO AND INSPEC GET CONTRACT FOR PV SYSTEM AND SMART ENERGY SYSTEM INSTALLATION AT THE OREGON SUSTAINABILITY CENTER IN PORTLAND
  • THERMO FISHER SCIENTIFIC SIGNS PACT WITH CINVEN TO ACQUIRE PHADIA
  • "STEM CELLS - THE DENTAL CONNECTION": CONTINUING EDUCATION PROGRAM FOR ORAL SURGEONS AND DENTISTS
  • DNA GENOTEK LAUNCHES OMNIGENE™" DISCOVER FOR INFECTIOUS DISEASE SAMPLING
  • THERMO FISHER SCIENTIFIC PURCHASES STERILIN
  • THERMO FISHER SCIENTIFIC ACHIEVES COMPLETE TAKE OVER OF DIONEX
  • THERMO FISHER SCIENTIFIC FULFILSTENDER OFFER TO ACQUIRE DIONEX CORPORATION
  • BIOSTORAGE TECHNOLOGIES, INC. NOW WITH GLOBAL BIOBANKING COMMUNITY
  • TRANS-HIT BIOMARKERS PARTICIPATES IN CQDM-FUNDED MCGILL UNIVERSITY PROJECT
  • LABVANTAGE PROVIDES COMPREHENSIVE DATA SOLUTIONS TO LABS AND IS TOPMOST INTEGRATED SOLUTION PROVIDER
  • 75 MILLION HPV TESTS AND STILL GOING STRONG, QIAGEN REACHES MILESTONE AND ANNOUNCES STRATEGY UPDATE FOR QIAENSEMBLE PROGRAM
  • SERACARE ANNOUNCES RENEWAL OF CONTRACT FROM NHLBI
  • THERMO FISHER SCIENTIFIC ANNOUNCES PLAN TO DEVELOP A MANUFACTURING UNIT IN SUZHOU, CHINA
  • CUSTOMER-FRIENDLY COMPLEX ANTIBODIES
  • PREVENTION FOR CERVICAL CANCER @RWANDA BY MERCK AND QIAGEN
  • ACQUISITION OF SOFTWARE POINT BY LABVANTAGE
  • PROMETIC SIGNS AGREEMENT WITH CELGENE CORPORATION FOR GLOBAL RIGHTS TO COMMERCIAL APPLICATION OF PROTEIN TECHNOLOGIES
  • CHART INDUSTRIES TAKES OVER CLEVER FELLOWS INNOVATION CONSORTIUM
  • THERMO FISHER SCIENTIFIC SELLS LANCASTER LABORATORIES AND ATHENA DIAGNOSTICS
  • STORE-A-TOOTH COLLABORATES WITH CORDON DE VIDA TO PRESERVE STEM CELLS FROM TEETH
  • BIOTECH ENTREPRENEURS LAUNCH ABCODIA AND CALL FOR COLLABORATIVE PARTNERS
  • CALIPER IS AN ACCEPTED PARTNER FOR HISTORXIN BIOMARKERS IN TISSUE
  • SPECIAL HUMAN CELLS DERIVED FROM STEM CELLS RESTORE MOVEMENT IN RATS WITH SPINAL CORD INJURY
  • ASTROCYTES DERIVED FROM HUMAN STEM CELLS IMPROVE THE LOCOMOTOR FUNCTIONS OF RATS WITH SPINAL CORD INJURY
  • CORD BLOOD AMERICA PURCHASE OF CORD BLOOD STEM CELLS STORED BY REPRODUCTIVE GENERATIVE INSTITUTE AN ILLINOIS FIRM
  • LIFESPAN OF BONE MARROW STEM CELLS PREDICTED THROUGH COMPUTER MODEL, SOLVES THE REGENERATIVE PROBLEMS
  • RECENT STUDY REVEAL A COMBINATION OF CELLASTIM AND OPTIFERRIN IS IDEAL FOR STEM CELL EXPANSION WHICH REPLACES NEED OF BLOOD PRODUCTS
  • CALIPER AND COVARIS COLLABORATED TO SIMPLIFY NEXT GENERATION SEQUENCING
  • GILEAD SCIENCES SIGNS AGREEMENT TO ACQUIRE CALISTOGA PHARMACEUTICALS
  • BIOKRYO GMBH BECOMES AN ASSOCIATE OF ESBB
  • SINGLE BLASTOMERE TECHNOLOGY SECURES PATENT TO GENERATE EMBRYONIC STEM CELLS ENSURING EMBRYO SAFETY
  • MESENCHYMAL STEM CELLS TO IMPROVE THE DAMAGED CELLS AFTER HEART ATTACK
  • STEMCELLS, INC. COMPLETES SECOND TRIAL OF HUCNS-SC(R) NEURAL STEM CELLS, A POTENTIAL TREATMENT FOR MYELINATION DISORDER
  • AMNIOTIC FLUID COLLECTED DURING THIRD TRIMESTER IS A RELIABLE SOURCE OF STEM CELLS FOR REGENERATIVE MEDICINE AND STEM CELL BANKING
  • CORD BLOOD AMERICA, INC. ANNOUNCES PURCHASE OF MINORITY INTEREST IN VIDAPLUS EXPECTED TO GAIN REVENUE AND POPULARITY IN EUROPE
  • INDUCED PLURIPOTENT STEM CELLS ARE SAFER AND CANCEROUS GROWTH MAY BE AVOIDED
  • MICRORNAS ENHANCES THE GENERATION OF INDUCED PLURIPOTENT STEM CELLS (IPS), THROUGH REPROGRAMMING SKIN STEM CELLS
  • BIOSTORAGE TECHNOLOGIES HOSTS GLOBAL SAMPLE MANAGEMENT BENCHMARKING SYMPOSIUM IN CONJUNCTION WITH BIOREPOSITORIES ASIA CONFERENCE
  • TECAN AND SWORD DETECTED HIGH PERFORMANCE IMMUNOASSAY TECHNOLOGY
  • BECKMAN COULTER'S IMPRESSIVE DISPLAYS AT LABAUTOMATION2011 TO HIGHLIGHT GENOMIC AND CELLULAR ANALYSIS WORKFLOW SOLUTIONS
  • NUGENAND CALIPER COLLABORATED FOR CLEARINGNEXT-GEN TECHNOLOGY BOTTLENECKS
  • HAMILTON PUTS IN AN INTEGRATED AUTOMATED COMPOUND STORAGE AND SCREENING SYSTEM
  • A HYDROSPEED™ PLATE WASHER BY TECAN
  • ROLE OF STEM CELLS IN REPAIRING DAMAGED HEART OF CHILDREN
  • THE FRAUNHOFER INSTITUTE IS FOCUSED TO STUDY THE CELL THERAPEUTIC PROCESSES IN ORDER TO OFFER SUITABLE SOLUTIONS
  • MIRNA THERAPEUTICS, INC. PUBLISH NEW DATA ON MIR-34 IN INHIBITING THE GROWTH OF CANCER CELLS
  • BIOCELLS, INC., TO STORE DENTAL PULP STEM CELLS WHICH AIDS IN STIMULATING NEURAL CELLS AND A SOURCE OF REGENERATIVE MEDICINE
  • NEOSTEM, INC.'S RECOMMENDED FOR THE FINANCIAL AWARD OF $1,700,000 DEVELOPING VERY SMALL EMBRYONIC-LIKE STEM CELLS WHICH IS A POTENTIAL CURE FOR OSTEOPOROSIS FROM DEPARTMENT OF DEFENSE PEER REVIEWED MEDICAL RESEARCH PROGRAM
  • BIOHEART REPORTS THE USE OF ADIPOSE DERIVED STEM CELLS IN CURING CRITICAL LIMB ISCHEMIA
  • POSITION OF DNA IN STEM CELL TRANSPLANT SUCCESS & FUNDING
  • THE CHEAPEST STEM CELL TRANSPLANT FROM INDIA
  • CHART INDUSTRIES ACQUIRED SEQUAL TECHNOLOGIES
  • THERMO FISHER SCIENTIFIC ACQUIRES LOMB SCIENTIFIC
  • THE BEST BIOINFORMATICS CORPORATION IS OCIMUM BIOSOLUTIONS IN 2010
  • CALIPER LIFE SCIENCES IS DONE WITH CRI ACQUISITION
  • GILEAD SCIENCES SIGNS AGREEMENT TO ACQUIRE ARRESTO BIOSCIENCES
  • IBBL AND WAFERGEN ENTER COLLABORATION IN RESEARCH AND EQUIPMENT
  • THERMO FISHER SCIENTIFIC GETS APPROVAL FOR ACQUISITION OF DIONEX
  • CALIPER LIFE SCIENCES OBTAINS CAMBRIDGE R&I
  • DECODE GENETICS ANNOUNCES DISCOVERY OF GENETIC MARKERS THAT IMPROVE THE POWER OF PSA TESTING
  • HUMAN STEM CELLS CALLED PARTHENOGENETIC CELLS, WHICH ARE DEVELOPED BY UNFERTILIZED HUMAN EGGS-ETHICAL CONSIDERATIONS AND MEDICAL ADVANTAGES
  • ADVANCED CELL TECHNOLOGY AND THE ROSLIN INSTITUTE ANNOUNCE AGREEMENT FOR STORAGE AND DISTRIBUTION OF EMBRYONIC STEM CELLS USING ACT'S BLASTOMERE TECHNOLOGY
  • STEM CELL TECHNOLOGY - A BREAKTHROUGH IN GROWING FUNCTIONAL INTESTINE TISSUE
  • ASM SOFTWARE IS RESTRUCTURED BY HAMILTON ACTIVE SAMPLE MANAGEMENT STORAGE TECHNOLOGIES
  • TECAN AND COVARIS COLLABORATED FOR FREEDOM EVOR
  • RURO LAUNCHES EZCOLONY 2011
  • ADVANCED CELL TECHNOLOGY CLEARED BY FDA FOR THE FIRST CLINICAL TRIAL ON USING RETINAL STEM CELLS FOR CURING STARGARDT'S MACULAR DYSTROPHY
  • EHSI: STEM CELLS COULD HELP HEART ATTACK VICTIMS
  • STEMCYTE, INC. RECEIVED TWO AWARDS TOTALING TO $488,950 FOR ADVANCED THERAPEUTIC APPLICATIONS OF UMBILICAL CORD BLOOD STEM CELLS FROM THE QUALIFYING THERAPEUTIC DISCOVERY PROJECT (QTDP)
  • SHRINK NANOTECHNOLOGIES REVEALS VIDEOS OF STEMDISC450 PROTOTYPE, A DEVICE FOR GROWING HUMAN EMBRYONIC STEM CELLS
  • X-BODY BIOSCIENCES AWARDED GRANT FOR THERAPEUTIC DISCOVERY PROJECT TARGETING METASTATIC TUMOR STEM CELLS
  • VIVAKOR SIGNS GLOBAL LICENSING AGREEMENT WITH MIT HOLDING FOR VIVATHERMIC VIALS
  • STEM CELLS REPAIR DAMAGED SPINAL CORD TISSUE IN RATS
  • ROCHE´S CELLAVISTA SYSTEM ENHANCES THE STUDY OF SELF RENEWAL OF EMBRYONIC STEM CELLS
  • BIOCISION INITIATES CRYOPREP SYSTEM FOR COMPETENT AND EXTREMELY REPRODUCIBLE CELL PRESERVATION
  • BIOMATRICA NEW-FANGLED STABILIZATION TECHNOLOGY USED FOR BLOOD DNA PRESERVATION
  • BIOMATRICA LAUNCHES DNAGARDR BLOOD AND DNASTABLER BLOOD
  • CEPHALON SIGNS AGREEMENT TO FUND CHEMGENEX
  • NEXUS BIOSYSTEMS PURCHASES REMP SAMPLE MANAGEMENT BUSINESS FROM TECAN GROUP
  • CEPHALON ACQUIRES MEPHA
  • TECAN IS FIRST CHOICE FOR QUALITY AND RELIABILITY
  • LARGE CAPACITY ULT FREEZER THE LATEST FROM NEW BRUNSWICK SCIENTIFIC
  • GERON ENTERS INTO A LICENSE AGREEMENT FOR PRODUCTION OF CHONDOCYTES FROM IPS
  • SHAKERS, INCUBATORS, FREEZERS GET NEW DATA LOGGING SOFTWARE
  • RURO INTRODUCES SCIENCY ELN 2.0 STANDARD - NEW VERSION OF SOFTWARE
  • CHART ACQUIRES CRYOTECH INTERNATIONAL
  • GUIDED ADULT STEM CELLS CAN EFFECTIVELY REPAIR HEARTS
  • SERACARE LIFE SCIENCES INTRODUCES NEW HIV SEROCONVERSION PANELS
  • ARUP LABORATORIES AND DECODE GENETIC IN PARTNERSHIP TO OFFER DECODE PROSTATECANCER™ TEST
  • THERMO FISHER SCIENTIFIC TAKES OVER FERMENTAS
  • NEXUS BIOSYSTEMS SIGNS AGREEMENT TO ACQUIRE TECAN'S REMP SAMPLE MANAGEMENT BUSINESS
  • ERAGEN BIOSCIENCES GETS FDA CLEARANCE FOR MULTICODE-RTX HSV 1 & 2 KIT WITH SEQWRIGHT'S BACKING
  • OCIMUM BIOSOLUTIONS COMMENCED WITH LIMS, BIOTRACKER™ LITE
  • OCIMUM BIOSOLUTIONS OFFERS BIOIT CONSULTING FOR R&D IN LIFE SCIENCES
  • NEW CULTURE DISH OVERCOMES THE LIMITATIONS IN HUMAN EMBRYONIC STEM CELL RESEARCH
  • THERMO FISHER SCIENTIFIC SIGNS CONTRACT TO ACQUIRE FERMENTAS
  • RURO INTRODUCES FREEZEERPRO MULTISITE
  • CALIPER LIFE SCIENCES SELLS PRODUCT LINES, RAPIDTRACER AND TURBOVAPR, TO BIOTAGE
  • PREVIEW OF CRYOXTRACT'S NOVEL AUTOMATED FROZEN SAMPLE ALIQUOTTER AT ISBER 2010
  • TECAN ASSESS RADIATION EXPOSURE WITH ARIZONA STATE UNIVERSITY
  • INDIVUMED BECOMES THE FIRST ISO-9001:2008 CERTIFIED BIOBANK IN THE WORLD
  • NEW-FANGLED CLEAN ROOM MONITORING SOLUTION BY VERITEQ
  • THERMO FISHER SCIENTIFIC ACQUIRES 'EASY-NLC' PROVIDER PROXEON
  • HUNT BIOSCIENCES SIGNS COLLABORATION AGREEMENT WITH TISSUE SOLUTIONS
  • STEM CELL THERAPY A MAJOR ROLE FOR ACUTE LUNG DAMAGE IN MICE
  • VAISALA ACQUIRES VERITEQ INSTRUMENTS
  • THERMO FISHER SCIENTIFIC AND LILLY MAKE FIVE-YEAR AGREEMENT FOR CLINICAL TRIAL MATERIALS RELATIONSHIP
  • ACCESS TO TISSUES FOR ONCOLOGY R & D
  • STRATEGIC ALLIANCE FOR SAMPLE STORAGE AND CONVERSION SERVICES
  • BIOCISION COLLABORATED WITH SERVA ELECTROPHORESIS
  • UNSWERVING WASHING NEXTERIONR PLATES BY TECANHYDROFLEX™
  • CARDIOVASCULAR GENETIC TESTING AT BERKELEY HEARTLAB MADE EASY WITH GENTEGRA™ DNA FROM GENVAULT
  • CALIPER ANNULS LAWSUIT AGAINST SHIMADZU
  • TRANS-HIT LAUNCHES "QUICK OPPORTUNITIES"
  • THERMO FISHER SCIENTIFIC TAKES OVER FINNZYMES WHOLLY
  • THERMO FISHER SCIENTIFIC ACQUIRES AHURA SCIENTIFIC
  • STARLIMS SHAREHOLDERS APPROVE OF ACQUISITION BY ABBOTT
  • VERITEQ'S 10-STEP GUIDE ON "HOW TO RESPOND TO (AND AVOID) FDA 483S"
  • BIOCISION LANDS NEW DISTRIBUTION PARTNER WITH BIOPHORETICS DEAL
  • AUTOMATION BOOSTS SAMPLE PREPARATION FOR NEXT-GENERATION SEQUENCING
  • U.S. NATIONAL CANCER INSTITUTE CHOOSES INDIVUMED TO STUDY THE INTEGRITY OF BIOSPECIMEN SAMPLING PROCEDURES
  • CALIPER LAUNCHES SCICLONE G3
  • THERMO FISHER SCIENTIFIC SIGNS FINAL AGREEMENT TO ACQUIRE AHURA SCIENTIFIC
  • ANNOUNCING THE LAUNCH OF SANYO PROFESSIONAL AIR WASHER PLUSTM FOR COMMERCIAL ENVIRONMENTS, SUPPRESSING VOCS, BACTERIA, AIRBORNE GERMS, MOLD, ODOR AND ALLERGENS
  • CALIPER AGREES TO LICENSE MICROFLUIDICS IP TO BECTON DICKINSON
  • GENTEGRA™ RNA INTRODUCED BY GENVAULT CORPORATION
  • OCIMUM BIOSOLUTIONS STANDS IN 4TH PLACE AS THE FASTEST GROWING TECHNOLOGY COMPANY
  • CRYOXTRACT COMPLETES SUCCESSFUL TESTING OF INNOVATIVE ROBOTIC FROZEN ALIQUOTTER
  • ACQUISITION OF STARLIMS ENHANCES ABBOTT'S DIAGNOSTICS PORTFOLIO AND EXPERTISE IN IM SYSTEMS; ALSO EXPANDS STARLIMS' PRESENCE ACROSS LABORATORY MARKETS
  • SUPPLY AGREEMENT WITH LIFE TECHNOLOGIES ANNOUNCED BY GENVAULT
  • NEXUS BIOSYSTEMS ACQUIRES AURORA BIOTECHNOLOGIES
  • RTS LIFE SCIENCE AND INNOVATIVE VISION TECHNOLOGY LAUNCHES TUBE AUDITOR
  • CALIPER INTRODUCES LIVING IMAGER 4.0 SOFTWARE
  • CHART ANNOUNCES CAIRE'S ACQUISITION OF COVIDIEN'S OXYGEN THERAPY BUSINESS
  • SANYO PROPOSES SPEEDY IN SITU H2O2 CELL CULTURE WITH CO2 INCUBATOR STERILIZATION METHOD
  • TISSUE SOLUTIONS WINS "NEXXUS' 2009 MOST PROMISING YOUNG LIFE SCIENCE AWARD"
  • CALIPER PARTNERS WITH SRU BIOSYSTEMS TO INTRODUCE LABEL-FREE, CELL-BASED GPSR ASSAY TECHNOLOGIES
  • BIOCISION SIGNS DISTRIBUTION DEAL WITH CAPITAL BIOSCIENCES
  • THERMO FISHER SCIENTIFIC LAUNCHES COPEPTIN ASSAY IN EUROPE
  • THE GREAT EXCHANGE - LIMS SWAPS FROM OCIMUM BIOSOLUTIONS
  • ORAGENER" DNA USED TO DISCOVER GENETIC LINK TO PODOCONIOSIS
  • THERMO FISHER SCIENTIFIC ACQUIRES B.R.A.H.M.S.
  • CALIPER INTRODUCES XENOLIGHT REDIJECT D-LUCIFERIN ULTRA
  • BECKMAN COULTER EXPANDS DRUGS OF ABUSE TEST MENU WITH BUPRENORPHINE ASSAY
  • THERMO FISHER SCIENTIFIC SIGNS AGREEMENT TO ACQUIRE B.R.A.H.M.S. AG
  • RESOURCEFUL DRUG EXPLORED WITH TECAN'S FREEDOM EVOR 75
  • ROBOTICS AND PROTEOMICS: A PROMISING PARTNERSHIP FOR BIOMARKER DISCOVERY
  • BIOCISION INITIATED COOLCELL FOR ALCOHOL-FREE CELL FREEZING
  • 454 LIFE SCIENCES, ELI LILLY AND SEQWRIGHT TEAM UP TO USE GENOMIC TECHNOLOGIES FOR PSYCHIATRIC DISORDERS
  • SEQWRIGHT COLLABORATES WITH ROCHE FOR RESEARCH ON GENETIC CAUSES FOR DILATED CARDIOMYOPATHY
  • CEPHALON GAINS CONTROLLING INTEREST IN ARANA THERAPEUTICS
  • INDIVUMED AND VENTANA ORGANIZE CANCER RESEARCH SYMPOSIUM
  • THERMO FISHER SCIENTIFIC ENTERS INTO AGREEMENT TO ACQUIRE BIOLAB
  • CENTRALIZED AND STANDARDIZED SOFTWARE SOLUTION - THE LATEST FROM GENVAULT CORPORATION
  • A SPECIAL TB DAY WITH AWARENESS CAMPAIGN
  • NATIONAL CANCER INSTITUTE'S (NCI) PROPOSAL FOR U.S.'S FIRST NATIONAL BIO-BANK
  • BECKMAN COULTER LAUNCHES GALLIOS™ FLOW CYTOMETRY SYSTEM
  • STARLIMS FEATURES IN $4M PROJECT SELECTED BY WORLD LEADER IN BIOTECH
  • TECAN'S NANOQUANT™ PLATE GETS UNDER THE SKIN OF STEM CELLS
  • DECODE RECEIVES CLINICAL LABORATORY LICENSE FROM THE STATE OF CALIFORNIA
  • ILLUMINA SNP GENOTYPING SERVICES BY GENE LOGIC
  • IMPRESSIVE PREVIEW OF CRYOXTRACT'S NOVEL ROBOTIC TECHNOLOGY AT LABAUTOMATION 2009
  • DATAWORKS DEVELOPMENT INTRODUCES FREEZERWORKS UL 4.0
  • DECODE LAUNCHES DECODEME CARDIO™ AND DECODEME CANCER™
  • BIOCISION'S ADVANCED TEMPERATURE MANAGEMENT IN MICROFUGE TUBES
  • TECAN NOW WITH DISPOSABLE TIPS FOR 96-MULTICHANNEL ARM™
  • A CERTIFIED SERVICE PROVIDER FOR NUGEN OVATIONR SYSTEMS IS OCIMUM BIOSOLUTIONS
  • RTS LIFE SCIENCE TO EXHIBIT FREE SAMPLE MANAGEMENT AUTOMATION AUDIT AT LABAUTOMATION 2009

H. MARKET TRENDS

  • ENHANCING EFFICIENCY AND SECURITY OF BIOREPOSITORIES
  • IMPROVING EFFICIENCY OF BIOBANKING BY AUTOMATION
  • INVENTORY MANAGEMENT OF SAMPLES IN BIOBANKS
  • SAMPLE QUANTITATION WITH MICROVOLUME TOOLS-THERMO SCIENTIFIC NANODROP 8000
  • SIGNIFICANCE OF BIOBANKS IN BIOMARKER DISCOVERY PROGRAMS
  • NEED FOR STANDARDIZED PROCEDURES IN BIOBANKS
  • ADVANCED IT DEVICES REJUVENATE BIOBANKING
  • PRESERVATION OF BIOLOGICAL SPECIMEN INTEGRITY
  • BIOMARKER DEVELOPMENT - KEYSTONE OF DIAGNOSIS AND TREATMENT
  • STANDARDIZATION AND AUTOMATION OF BIOBANKS - NEED OF THE HOUR

H. BIOREPOSITORIES / BIOBANKING - INDUSTRY LEADERS

  • BECKMAN COULTER
  • CALIPER LIFE SCIENCES, INC.
  • CEPHALON, INC.
  • CHART INDUSTRIES, INC.
  • GILEAD SCIENCES, INC.
  • MYLAN, INC.
  • RAND CORPORATION
  • SERACARE LIFE SCIENCES
  • TECAN
  • AASTROM BIOSCIENCES, INC.
  • BIOHEART, INC.
  • CORD BLOOD REGISTRY
  • CRYOLIFE, INC.
  • OSIRIS THERAPEUTICS, INC.
  • SIGMA-ALDRICH, CO.
  • STEM CELL INNOVATIONS, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • VIACORD
  • RENEURON GROUP PLC
  • CRYOCORD SDN. BHD.
  • BARBER NICHOLS
  • CHARTER MEDICAL, LTD.
  • CRYOMAGNETICS, INC.
  • CUSTOM BIOGENIC SYSTEMS
  • ORIGEN BIOMEDICAL, INC.
  • CRYOGENETICS AS
  • LINDE GAS CRYOSERVICES B.V.
  • CRYOLOGIC PTY. LTD.
  • GENESEARCH

I. BIOREPOSITORIES / BIOBANKING - A LOOK AHEAD..!!

J. BIOREPOSITORIES / BIOBANKING - KEY COMPANY PROFILES

  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC

IV. INDUSTRY COMPANY DATABASE

  • KEY BIOBANKS INVOLVED IN ANIMALS AND PLANTS
  • BIOBANKS ASSOCIATED WITH BBMRI IN EUROPE

V. APPENDIX

  • A. RESEARCH FOCUS
  • B. ABOUT AXIS RESEARCH MIND
  • C. DISCLAIMER
  • D. FEEDBACK

LIST OF TABLES/CHARTS

I. REPORT FOCUS

  • 1. MAJOR BIOREPOSITORIES GROWTH RATES FOR STORAGE OF MATERIAL - BY TYPE IN COMBINATIONS - 2010-%
  • 2. POTENTIAL NEEDS AND USES FOR BIOSPECIMENS BY CONSTITUENCY
  • 3. GLOBAL BIOBANKS BY RESEARCH MODELS - 2010
  • 4. CHARACTERISTICS OF TISSUE SAMPLE COLLECTION BY TYPE OF CANCER
  • 5. GLOBAL BIOMARKERS MARKET FORECASTS IN CLINICAL USE BY THERAPEUTIC AREA - (2009-2015, IN USD$ MILLION)
  • 6. GLOBAL BIOMARKERS MARKET FORECASTS IN CLINICAL USE BY THERAPEUTIC AREA - % OF MARKET VALUE - (2009 - 2012 - 2015)

BIOREPOSITORIES / BIOBANKING - NORTH AMERICAN MARKET BRIEFING APPLICATIONS

  • 7. BIOREPOSITORIES - APPLICATIONS - STEM CELLS, BLOOD PRODUCTS, HUMAN, VETERINARY, ADVANCED APPLICATIONS AND OTHERS FOR NORTH AMERICA - (2009-2015, IN USD$ MILLION)
  • 8. BIOREPOSITORIES - APPLICATIONS - STEM CELLS, BLOOD PRODUCTS, HUMAN, VETERINARY, ADVANCED APPLICATIONS AND OTHERS - % OF NORTH AMERICAN MARKET VALUE - (2009 - 2012 - 2015)
  • 9. BIOREPOSITORIES - ADVANCE APPLICATIONS MARKET - DRUG DISCOVERY, GENOMICS AND FORENSICS FOR NORTH AMERICA - (2009-2015, IN USD$ MILLION)
  • 10. BIOREPOSITORIES - ADVANCE APPLICATIONS - DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF NORTH AMERICAN MARKET VALUE - (2009 - 2012 - 2015)

BIOREPOSITORIES / BIOBANKING - EUROPEAN MARKET BRIEFING

  • 11. INVENTORY ON EXISTING POPULATION BIOBANKS IN EUROPE - MARCH 2011
  • 12. BIOSPECIMENS COLLECTED BY VARIOUS BIOBANKS FROM THEIR ESTABLISHMENT IN EUROPE

APPLICATIONS

  • 13. BIOREPOSITORIES - APPLICATIONS - STEM CELLS, BLOOD PRODUCTS, HUMAN, VETERINARY, ADVANCED APPLICATIONS AND OTHERS FOR EUROPE - (2009-2015, IN USD$ MILLION)
  • 14. BIOREPOSITORIES - APPLICATIONS - STEM CELLS, BLOOD PRODUCTS, HUMAN, VETERINARY, ADVANCED APPLICATIONS AND OTHERS - % OF EUROPEAN MARKET VALUE - (2009 - 2012 - 2015)
  • 15. BIOREPOSITORIES - ADVANCE APPLICATIONS MARKET - DRUG DISCOVERY, GENOMICS AND FORENSICS FOR EUROPE - (2009-2015, IN USD$ MILLION)
  • 16. BIOREPOSITORIES - ADVANCE APPLICATIONS - DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF EUROPEAN MARKET VALUE - (2009 - 2012 - 2015)

BIOREPOSITORIES / BIOBANKING - ASIA-PACIFIC MARKET BRIEFING APPLICATIONS

  • 17. BIOREPOSITORIES - APPLICATIONS - STEM CELLS, BLOOD PRODUCTS, HUMAN, VETERINARY, ADVANCED APPLICATIONS AND OTHERS FOR ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
  • 18. BIOREPOSITORIES - APPLICATIONS - STEM CELLS, BLOOD PRODUCTS, HUMAN, VETERINARY, ADVANCED APPLICATIONS AND OTHERS - % OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
  • 19. BIOREPOSITORIES - ADVANCE APPLICATIONS MARKET - DRUG DISCOVERY, GENOMICS AND FORENSICS FOR ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
  • 20. BIOREPOSITORIES - ADVANCE APPLICATIONS - DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)

II. MARKET ANALYSIS

  • A. BIOREPOSITORIES / BIOBANKING: APPLICATIONS - SEGMENTATION
  • 21. GLOBAL BIOREPOSITORIES - SEGMENTATION BY APPLICATIONS

B. BIOREPOSITORIES - GLOBAL

  • 22. BIOREPOSITORIES - GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2009-2015, IN USD$ MILLION)
  • 23. BIOREPOSITORIES - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 24. BIOREPOSITORIES - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

B1. BIOREPOSITORIES - BY - COUNTRY ANALYSIS

  • 25. BIOREPOSITORIES - USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
  • 26. BIOREPOSITORIES - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
  • 27. BIOREPOSITORIES - BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
  • 28. BIOREPOSITORIES - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
  • 29. BIOREPOSITORIES - AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
  • 30. BIOREPOSITORIES - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
  • 31. BIOREPOSITORIES - ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 32. BIOREPOSITORIES - % OF ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

I. BIOREPOSITORIES - APPLICATIONS - GLOBAL

  • 33. BIOREPOSITORIES - APPLICATIONS - STEM CELLS, BLOOD PRODUCTS, HUMAN, VETERINARY, ADVANCED APPLICATIONS AND OTHERS FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2009-2015, IN USD$ MILLION)
  • 34. BIOREPOSITORIES - APPLICATIONS - STEM CELLS, BLOOD PRODUCTS, HUMAN, VETERINARY, ADVANCED APPLICATIONS AND OTHERS - % OF GLOBAL MARKET VALUE - (2009 - 2012 - 2015)

BIOREPOSITORIES - APPLICATIONS - GEOGRAPHIC REGION

  • I.A. STEM CELLS
  • 35. BIOREPOSITORIES - APPLICATIONS - STEM CELLS - BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 36. BIOREPOSITORIES - APPLICATIONS - STEM CELLS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
  • 37. BIOREPOSITORIES - APPLICATIONS - STEM CELLS FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
  • 38. BIOREPOSITORIES - APPLICATIONS - STEM CELLS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
  • 39. BIOREPOSITORIES - APPLICATIONS - STEM CELLS FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
  • 40. BIOREPOSITORIES - APPLICATIONS - STEM CELLS - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
  • 41. BIOREPOSITORIES - APPLICATIONS - STEM CELLS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
  • 42. BIOREPOSITORIES - APPLICATIONS - STEM CELLS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
  • 43. BIOREPOSITORIES - APPLICATIONS - STEM CELLS FOR ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 44. BIOREPOSITORIES - APPLICATIONS - STEM CELLS - % OF ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

I.B. BLOOD PRODUCTS

  • 45. BIOREPOSITORIES - APPLICATIONS - BLOOD PRODUCTS- BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 46. BIOREPOSITORIES - APPLICATIONS - BLOOD PRODUCTS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
  • 47. BIOREPOSITORIES - APPLICATIONS - BLOOD PRODUCTS FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
  • 48. BIOREPOSITORIES - APPLICATIONS - BLOOD PRODUCTS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
  • 49. BIOREPOSITORIES - APPLICATIONS - BLOOD PRODUCTS FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
  • 50. BIOREPOSITORIES - APPLICATIONS - BLOOD PRODUCTS - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
  • 51. BIOREPOSITORIES - APPLICATIONS - BLOOD PRODUCTS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
  • 52. BIOREPOSITORIES - APPLICATIONS - BLOOD PRODUCTS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
  • 53. BIOREPOSITORIES - APPLICATIONS - BLOOD PRODUCTS FOR ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD -
  • (2009-2015, IN USD$ MILLION)
  • 54. BIOREPOSITORIES - APPLICATIONS - BLOOD PRODUCTS - % OF ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

I.C. HUMAN

  • 55. BIOREPOSITORIES - APPLICATIONS - HUMAN - BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 56. BIOREPOSITORIES - APPLICATIONS - HUMAN - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
  • 57. BIOREPOSITORIES - APPLICATIONS - HUMAN FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
  • 58. BIOREPOSITORIES - APPLICATIONS - HUMAN - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
  • 59. BIOREPOSITORIES - APPLICATIONS - HUMAN FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
  • 60. BIOREPOSITORIES - APPLICATIONS - HUMAN - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
  • 61. BIOREPOSITORIES - APPLICATIONS - HUMAN FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
  • 62. BIOREPOSITORIES - APPLICATIONS - HUMAN - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
  • 63. BIOREPOSITORIES - APPLICATIONS - HUMAN FOR ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 64. BIOREPOSITORIES - APPLICATIONS - HUMAN - % OF ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

I.D. VETERINARY

  • 65. BIOREPOSITORIES - APPLICATIONS - VETERINARY- BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 66. BIOREPOSITORIES - APPLICATIONS - VETERINARY- % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
  • 67. BIOREPOSITORIES - APPLICATIONS - VETERINARY FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
  • 68. BIOREPOSITORIES - APPLICATIONS - VETERINARY - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
  • 69. BIOREPOSITORIES - APPLICATIONS - VETERINARY FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
  • 70. BIOREPOSITORIES - APPLICATIONS - VETERINARY - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
  • 71. BIOREPOSITORIES - APPLICATIONS - VETERINARY FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
  • 72. BIOREPOSITORIES - APPLICATIONS - VETERINARY - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
  • 73. BIOREPOSITORIES - APPLICATIONS - VETERINARY FOR ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 74. BIOREPOSITORIES - APPLICATIONS - VETERINARY - % OF ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

I.E. ADVANCED APPLICATIONS

  • 75. BIOREPOSITORIES - ADVANCED APPLICATIONS - BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 76. BIOREPOSITORIES - ADVANCED APPLICATIONS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
  • 77. BIOREPOSITORIES - ADVANCED APPLICATIONS FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
  • 78. BIOREPOSITORIES - ADVANCED APPLICATIONS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
  • 79. BIOREPOSITORIES - ADVANCED APPLICATIONS FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
  • 80. BIOREPOSITORIES - ADVANCED APPLICATIONS - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
  • 81. BIOREPOSITORIES - ADVANCED APPLICATIONS FORAUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
  • 82. BIOREPOSITORIES - ADVANCED APPLICATIONS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
  • 83. BIOREPOSITORIES - ADVANCED APPLICATIONS FOR ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 84. BIOREPOSITORIES - ADVANCED APPLICATIONS - % OF ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

BIOREPOSITORIES - ADVANCE APPLICATIONS - BY TYPE

  • 85. BIOREPOSITORIES -ADVANCE APPLICATIONS MARKET - DRUG DISCOVERY, GENOMICS AND FORENSICS FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2009-2015, IN USD$ MILLION)
  • 86. BIOREPOSITORIES - ADVANCE APPLICATIONS - DRUG DISCOVERY, GENOMICS AND FORENSICS - % OF GLOBAL MARKET VALUE - (2009 - 2012 - 2015)

BIOREPOSITORIES - ADVANCE APPLICATIONS - BY TYPE - GEOGRAPHIC REGION

1. DRUG DISCOVERY

  • 87. BIOREPOSITORIES - ADVANCE APPLICATIONS MARKET -DRUG DISCOVERY BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 88. BIOREPOSITORIES - ADVANCE APPLICATIONS - DRUG DISCOVERY - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
  • 89. BIOREPOSITORIES - ADVANCE APPLICATIONS - DRUG DISCOVERY FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
  • 90. BIOREPOSITORIES - ADVANCE APPLICATIONS - DRUG DISCOVERY - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
  • 91. BIOREPOSITORIES - ADVANCE APPLICATIONS - DRUG DISCOVERY FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
  • 92. BIOREPOSITORIES - ADVANCE APPLICATIONS - DRUG DISCOVERY - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
  • 93. BIOREPOSITORIES - ADVANCE APPLICATIONS - DRUG DISCOVERY FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
  • 94. BIOREPOSITORIES - ADVANCE APPLICATIONS - DRUG DISCOVERY - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
  • 95. BIOREPOSITORIES - ADVANCE APPLICATIONS - DRUG DISCOVERY FOR ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 96. BIOREPOSITORIES - ADVANCE APPLICATIONS - DRUG DISCOVERY - % OF ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

2. GENOMICS

  • 97. BIOREPOSITORIES - ADVANCE APPLICATIONS MARKET -GENOMICS BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 98. BIOREPOSITORIES - ADVANCE APPLICATIONS - GENOMICS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
  • 99. BIOREPOSITORIES - ADVANCE APPLICATIONS - GENOMICS FORUSA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
  • 100. BIOREPOSITORIES - ADVANCE APPLICATIONS - GENOMICS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
  • 101. BIOREPOSITORIES - ADVANCE APPLICATIONS - GENOMICS FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
  • 102. BIOREPOSITORIES - ADVANCE APPLICATIONS - GENOMICS - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
  • 103. BIOREPOSITORIES - ADVANCE APPLICATIONS - GENOMICS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
  • 104. BIOREPOSITORIES - ADVANCE APPLICATIONS - GENOMICS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
  • 105. BIOREPOSITORIES - ADVANCE APPLICATIONS - GENOMICS FOR ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 106. BIOREPOSITORIES - ADVANCE APPLICATIONS - GENOMICS - % OF ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

3. FORENSICS

  • 107. BIOREPOSITORIES - ADVANCE APPLICATIONS MARKET -FORENSICS BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 108. BIOREPOSITORIES - ADVANCE APPLICATIONS - FORENSICS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
  • 109. BIOREPOSITORIES - ADVANCE APPLICATIONS - FORENSICS FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
  • 110. BIOREPOSITORIES - ADVANCE APPLICATIONS - FORENSICS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
  • 111. BIOREPOSITORIES - ADVANCE APPLICATIONS - FORENSICS FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
  • 112. BIOREPOSITORIES - ADVANCE APPLICATIONS - FORENSICS - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
  • 113. BIOREPOSITORIES - ADVANCE APPLICATIONS - FORENSICS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
  • 114. BIOREPOSITORIES - ADVANCE APPLICATIONS - FORENSICS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
  • 115. BIOREPOSITORIES - ADVANCE APPLICATIONS - FORENSICS FOR ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 116. BIOREPOSITORIES - ADVANCE APPLICATIONS - FORENSICS - % OF ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

II.F. OTHER APPLICATIONS

  • 117. BIOREPOSITORIES - OTHER APPLICATIONS - BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 118. BIOREPOSITORIES - OTHER APPLICATIONS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
  • 119. BIOREPOSITORIES - OTHER APPLICATIONS FORUSA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
  • 120. BIOREPOSITORIES - OTHER APPLICATIONS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
  • 121. BIOREPOSITORIES - OTHER APPLICATIONS FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
  • 122. BIOREPOSITORIES - OTHER APPLICATIONS - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, ITALY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
  • 123. BIOREPOSITORIES - OTHER APPLICATIONS FORAUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
  • 124. BIOREPOSITORIES - OTHER APPLICATIONS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
  • 125. BIOREPOSITORIES - OTHER APPLICATIONS FOR ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • 126. BIOREPOSITORIES - OTHER APPLICATIONS - % OF ARGENTINA, BRAZIL, COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

C. GROWTH RATE ANALYSIS

  • C.1. GLOBAL BIOREPOSITORIES MARKET GROWTH RATES
  • 127. BIOREPOSITORIES MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015)

1. BIOREPOSITORIES MARKET - APPLICATIONS GLOBAL BIOREPOSITORIES APPLICATIONS TYPES - GROWTH RATES 128. BIOREPOSITORIES APPLICATIONS - % GROWTH RATE FORECASTS FOR STEM CELLS, BLOOD PRODUCTS, HUMAN, VETERINARY, ADVANCED APPLICATIONS AND OTHERS - (2009-2015) 129. STEM CELLS MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015) 130. BLOOD PRODUCTS MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015) 131. HUMAN BIOBANKING MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015) 132. VETERINARY MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015) 133. ADVANCED APPLICATIONS MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015) 134. ADVANCED APPLICATIONS TYPES - % GROWTH RATE FORECASTS FOR DRUG DISCOVERY, GENOMICS AND FORENSICS - (2009-2015) 135. DRUG DISCOVERY MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015) 136. GENOMICS MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015) 137. FORENSICS MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015)

III. INDUSTRY OVERVIEW

  • 138. STEM CELLS COMPANIES IN DIFFERENT COUNTRIES WITH THEIR YEAR OF ESTABLISHMENT, ACCREDITATION AND STEM CELLS BANKING STORAGE PRICE STRUCTURE
  • 139. STEM CELLS BANKING STORAGE PRICE STRUCTURE AROUND THE WORLD
  • 140. STEM CELLS COMPANIES IN DIFFERENT COUNTRIES WITH THEIR NUMBER OF TRANSPLANTS
  • 141. WORLDWIDE CORD BLOOD BANKS GROWTH RATE (%) FOR 2009 AND 2010
  • 142. JAPAN CORD BLOOD BANK NETWORK COLLECTED UNITS, 2009
  • 143. GLOBAL STEM CELLS BIOBANKING FORECASTS BY TYPE - (2009-2015, IN USD$ MILLION)
  • 144. LIST OF APPLICATIONS FOR STEM CELL TRANSPLANTATION
  • 145. BONE MARROW DONATIONS, PERIPHERAL BLOOD STEM CELL DONATIONS AND CORD BLOOD UNITS ACROSS 21 COUNTRIES (2007 - 2008 - 2009)
  • 146. WORLDWIDE ACTIVE CORD BLOOD BANKS WITH THEIR ACCREDITATION & CBB'S INVENTORY UNITS
  • 147. GLOBAL LIST OF KEY PLAYERS IN BIOREPOSITORIES / BIOBANKING INDUSTRY
  • 148. AFFYMETRIX, INC.: BREAKDOWN OF TOTAL SALES BY GEOGRAPHY, R&D EXPENSES AND PRODUCT SALES - (2010-2009-2008, IN USD THOUSAND)
  • 149. BECKMAN COULTER: BREAKDOWN OF TOTAL REVENUE BY SEGMENT/CATEGORY (2009 AND 2008, IN USD MILLION)
  • 150. BECKMAN COULTER: BREAKDOWN OF TOTAL REVENUE BY GEOGRAPHIC REGION - (2009 AND 2008, IN USD MILLION)
  • 151. BECKMAN COULTER: INSTRUMENT SALES - (2009-2008-2007-2006-2005, IN USD MILLION)
  • 152. CALIPER LIFE SCIENCES, INC.: BREAKDOWN OF REVENUES BY SEGMENT - (2009 AND 2010, IN USD THOUSAND)
  • 153. CALIPER LIFE SCIENCES, INC.: RESEARCH AND DEVELOPMENT EXPENSES - (2010-2009-2008, IN USD MILLION)
  • 154. CALIPER LIFE SCIENCES, INC.: BREAKDOWN OF REVENUES BY GEOGRAPHY - (2010-2009-2008, IN USD THOUSAND)
  • 155. CEPHALON, INC.: TOTAL REVENUES & RESEARCH AND DEVELOPMENT COSTS - (2008 AND 2009, IN USD MILLION)
  • 156. CEPHALON, INC.: SALES BY PRODUCT IN USA & EUROPE - (2008 AND 2009, USD THOUSAND)
  • 157. CHART INDUSTRIES, INC.: BREAKDOWN OF NET SALES BY INDUSTRY SEGMENTS - (2010-2009-2008, IN USD MILLION)
  • 158. GILEAD SCIENCES, INC.: BREAKDOWN OF NET SALES BY GEOGRAPHIC AREA - (2010-2009-2008, IN USD THOUSAND)
  • 159. GILEAD SCIENCES, INC.: BREAKDOWN OF PRODUCT SALES BY SEGMENT - (2010-2009-2008, IN USD THOUSAND)
  • 160. GILEAD SCIENCES, INC.: MAJOR MARKETED PRODUCT PATENTS EXPIRATION IN UNITED STATES AND EUROPE
  • 161. GILEAD SCIENCES, INC.: BREAKDOWN OF MAJOR R&D EXPENSES BY COMPONENT - (2010-2009-2008, IN USD THOUSAND)
  • 162. MYLAN, INC.: TOTAL REVENUES & RESEARCH AND DEVELOPMENT EXPENSES - (2008 AND 2009, IN USD THOUSAND)
  • 163. MYLAN, INC.: PRODUCT RIGHTS AND LICENSES VALUE BY THERAPEUTIC AREA - (2008 AND 2009, IN USD THOUSAND)
  • 164. MYLAN, INC.: BREAKDOWN OF NET REVENUES BY THERAPEUTIC AREA - (2008 AND 2009, IN USD THOUSAND)
  • 165. MYLAN, INC.: BREAKDOWN OF NET REVENUES BY GEOGRAPHIC AREA - (2008 AND 2009, IN USD THOUSAND)
  • 166. QIAGEN: BREAKDOWN OF NET REVENUE BY GEOGRAPHY - (IN USD THOUSAND, 2010-2009-2008)
  • 167. QIAGEN: BREAKDOWN OF LEADING SEGMENTS AND TYPES - 2010 %AGE GROWTH RATES
  • 168. RAND CORPORATION: TOTAL REVENUES & RESEARCH & DEVELOPMENT EXPENSES (2009-2010, IN USD THOUSAND)
  • 169. SERACARE LIFE SCIENCES: TOTAL REVENUE & RESEARCH AND DEVELOPMENT EXPENSES - (2010-2009-2008, IN USD THOUSAND)
  • 170. SERACARE LIFE SCIENCES: BREAKDOWN OF REVENUE BY SEGMENT - (2010-2009-2008, IN USD MILLION)
  • 171. THERMO FISHER SCIENTIFIC, INC.: BREAKDOWN OF TOTAL REVENUE BY SEGMENT & RESEARCH AND DEVELOPMENT EXPENSES - (2010-2009-2008, IN USD MILLION)
  • 172. THERMO FISHER SCIENTIFIC, INC.: BREAKDOWN OF TOTAL REVENUE BY GEOGRAPHIC REGION - (2010-2009-2008, IN USD MILLION)
  • 173. THERMO FISHER SCIENTIFIC, INC.: BREAKDOWN OF TOTAL REVENUE BY END-USE MARKET - (2010, IN USD MILLION)
  • 174. THERMO FISHER SCIENTIFIC, INC.: BREAKDOWN OF TOTAL REVENUE BY PRODUCT CATEGORY - (2010, IN USD MILLION)
  • 175. TECAN: BREAKDOWN OF NET SALES BY GEOGRAPHIC REGION & RESEARCH AND DEVELOPMENT EXPENSES - (2010-2009-2008, IN CHF MILLION)
  • 176. TECAN: BREAKDOWN OF NET SALES BY BUSINESS SEGMENT - (2010-2009-2008, IN CHF MILLION)

KEY COMPANY PROFILES

NORTH AMERICA

  • AASTROM BIOSCIENCES, INC.
  • ACORDA THERAPEUTICS, INC.
  • ADVANCED CELL TECHNOLOGY, INC.
  • AFFYMETRIX, INC.
  • ALPHA CORD, INC.
  • ANGIOBLAST SYSTEMS, INC.
  • ATGC LABS
  • AUTOGEN, INC.
  • BARBER NICHOLS
  • BECKMAN COULTER, INC.
  • BIOCISION
  • BIOHEART, INC.
  • BIOLIFE SOLUTIONS, INC.
  • BIOLOGICAL SPECIMEN INVENTORY SYSTEM
  • BIOMATRICA, INC.
  • BIOSTORAGE, LLC.
  • CALIPER LIFE SCIENCES, INC.
  • CARACO PHARMACEUTICAL LABORATORIES, LTD.
  • CELL THERAPEUTICS, INC.
  • CEPHALON, INC.
  • CHART INDUSTRIES, INC.
  • CHARTER MEDICAL, LTD.
  • CORCELL, INC.
  • CORD BLOOD REGISTRY
  • CORE DYNAMICS (USA), INC.
  • CRYOLIFE, INC.
  • CRYOMAGNETICS, INC.
  • CRYOPLUS, INC.
  • CRYOXTRACT
  • CUSTOM BIOGENIC SYSTEMS
  • DATAWORKS DEVELOPMENT, INC.
  • DNA GENOTEK, INC.
  • EPL ARCHIEVES, INC.
  • GENVAULT CORPORATION
  • GENZYME CORP.
  • GIESERLAB, INC.
  • GILEAD SCIENCES, INC.
  • HAMILTON STORAGE TECHNOLOGIES
  • LABVANTAGE SOLUTIONS, INC.
  • LABWARE, INC.
  • LIFENET HEALTH
  • MILLIPORE CORPORATION
  • MYLAN, INC.
  • NEOSTEM, INC.
  • NEW BRUNSWICK SCIENTIFIC
  • NEXUS BIOSYSTEMS GMBH
  • NOVARE BIOLOGISTICS
  • ORIGEN BIOMEDICAL, INC.
  • OSIRIS THERAPEUTICS, INC.
  • PACIFIC BIO-MATERIAL MANAGEMENT, INC.
  • PROMEDDX, LLC
  • PROVIA LABORATORIES, LLC
  • QIAGEN
  • RAND CORPORATION
  • RURO
  • SANYO BIOMEDICAL
  • SCIENTIFIC INSTRUMENTS, INC.
  • SEQWRIGHT DNA TECHNOLOGY SERVICES
  • SERACARE LIFE SCIENCES
  • SIGMA-ALDRICH, CO.
  • SP SCIENTIFIC
  • SPECTROCELL, INC.
  • STARLIMS CORPORATION
  • STEELGATE, INC.
  • STEM CELL INNOVATIONS, INC.
  • STEM CELLS THERAPEUTICS, CORP.
  • STEM CELLS, INC.
  • STEMCELL TECHNOLOGIES, INC.
  • STEMLIFELINE SCIENCES, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • THERMOGENESIS CORP.
  • TRANS-HIT BIOMARKERS, INC.
  • VERITEQ INSTRUMENTS, INC.,
  • VIACELL, INC.
  • VIACORD
  • VITAL THERAPIES, INC.
  • WHEATON SCIENCE PRODUCTS, INC.

EUROPE

  • AQIX
  • B & C GROUP
  • BBMRI
  • BIOBANK AS
  • BIOBANK IRELAND TRUST
  • BIOKRYO GMBH
  • BIOREP SRL P.IVA
  • BIOSTORAGE TECHNOLOGIES, INC.
  • BOEHRINGER INGELHEIM, GMBH
  • CELLS4LIFE, LTD.
  • CRYO BIO SYSTEM
  • CRYOGENETICS AS
  • CRYO-SAVE, AG
  • DEBIOPHARM GROUP
  • DECODE GENETICS
  • GE HEALTHCARE
  • GENESISBPS
  • HIGHRES BIOSOLUTIONS
  • HUNT BIOSCIENCES
  • INDIVUMED
  • LIFEGENE BIOBANK
  • LIFELINES COHORT AND BIOBANK
  • LINDE GAS CRYOSERVICES B.V.
  • MODUL-BIO SAS
  • MTS CRYOSTORES UK LTD
  • NORAY BIOINFORMATICS S.L.U.
  • RENEURON GROUP PLC
  • RTS LIFE SCIENCE
  • SANOFI AVENTIS
  • SOVENTEC GMBH
  • STIRLING CRYOGENICS & REFRIGERATION BV
  • TECAN
  • TISSUE SOLUTIONS
  • UK STEM CELL BANK

ASIA-PACIFIC

  • COLE PARMER INSTRUMENT, CO.
  • CORDLIFE PTE., LTD.
  • CRYOCORD SDN. BHD.
  • CRYOLOGIC PTY. LTD.
  • GENESEARCH
  • HAIMEN UNITED LABORATORY EQUIPMENT DEVELOPMENT CO., LTD.
  • OCIMUM BIOSCIENCES
  • RELIANCE LIFE SCIENCES
  • THERAVITAE CO. LTD.
Back to Top